Novel Alternate Vismodegib Dosing For Advanced Basal Carcinomas

This case series study evaluates a novel alternate dosing regimen of vismodegib that has led to decreased toxicity and eliminates the need for a loading dose.

http://ift.tt/2j9kg0l